Therapy for Skin Malignancies

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on Therapy for Skin Malignancies

Fig. 1 Radioactivity distribution within the patch (a). 166Ho-impregnated patch for skin cancer treatment. The size and shape can be easily adjusted according to those of cancers or precancerous lesions (b)….

read more

Protection of Staff and Public

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on Protection of Staff and Public

Nuclide Radiation type T1/2 Eβ.max p Eγ p Dose rate [mSv/h GBq] [keV] [%] [keV] [%] in 30 cm from point sourcea in contact with 5 ml syringe P-32 β- 14.3 d 1710…

read more

in Accidental Radiation Exposure

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on in Accidental Radiation Exposure

Fig. 1 Approximate time course of clinical manifestations following exposure to levels from 1 to over 2 Gy. George et al. (2007) The early or prodromal phase response from exposure to ionizing…

read more

in Metastatic Colorectal Cancer

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on in Metastatic Colorectal Cancer

Radionuclide Emission Half-life Range Approximate cell diameters 131Iodine ß 8.0 d 0.08–2.3 mm 10–230 90Yttrium ß 64.1 h 4.0–11.3 mm 400–1100 177Lutetium ß 6.7 d 0.04–1.8 mm 4–180 188Rhenium ß 17.0 h 1.9–10.4 mm 200–1000 67Copper ß 61.9 d…

read more

Probes for Molecular Imaging

Sep 1, 2016 by in NUCLEAR MEDICINE Comments Off on Probes for Molecular Imaging

Fig. 1 Targeted and activatable probes are the kinds of agent used most widely in molecular imaging. Targeted probes bind via a ligand to their designated target, with the prototypical ligand…

read more
Premium Wordpress Themes by UFO Themes